diquafosol has been researched along with Sjogren's Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremond-Gignac, D; Chiambaretta, F; Gicquel, JJ | 1 |
| Ikeda, C; Koh, S; Maeda, N; Nishida, K; Oie, Y; Soma, T; Tsujikawa, M; Watanabe, H | 1 |
| Kato, H; Kinoshita, S; Komuro, A; Sonomura, Y; Yokoi, N | 1 |
| Kato, H; Kinoshita, S; Yokoi, N | 1 |
| Hyon, JY; Jeon, HS | 1 |
1 review(s) available for diquafosol and Sjogren's Syndrome
| Article | Year |
|---|---|
Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.
Topics: Humans; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Sjogren's Syndrome; Uracil Nucleotides; Xerophthalmia | 2014 |
1 trial(s) available for diquafosol and Sjogren's Syndrome
| Article | Year |
|---|---|
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.
Topics: Administration, Topical; Aged; Double-Blind Method; Female; Humans; Male; Ophthalmic Solutions; Pilot Projects; Polyphosphates; Prospective Studies; Purinergic P2Y Receptor Agonists; Sjogren's Syndrome; Tears; Uracil Nucleotides | 2016 |
3 other study(ies) available for diquafosol and Sjogren's Syndrome
| Article | Year |
|---|---|
Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
Topics: Administration, Topical; Aged; Aqueous Humor; Corneal Wavefront Aberration; Female; Humans; Keratoconjunctivitis Sicca; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Sjogren's Syndrome; Surveys and Questionnaires; Tears; Uracil Nucleotides | 2014 |
Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Topics: Aged; Drug Administration Schedule; Dry Eye Syndromes; Female; Humans; Lubricant Eye Drops; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Sjogren's Syndrome; Tears; Uracil Nucleotides | 2015 |
The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Topics: Adult; Aged; Dry Eye Syndromes; Female; Humans; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Retrospective Studies; Sjogren's Syndrome; Uracil Nucleotides | 2016 |